ResidualPlaybeta Open the radar

EBOLA VILLAGE

indie_games_studio · 2025 · $16.99 · Action · deal grade B

Measured on 2026-09-23 18:58 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

  • Estimated net residual revenue: $503 to $755 per month
  • Opportunity: $849 per month at x1.35 dormancy
  • Estimated lifetime owners: 14.8k
  • 79% positive across 419 reviews · 4.4 reviews/month

Why it's flagged

  • Developer silent for 16 months
  • Studio quiet across its whole catalog

Analyst notes (AI-assisted)

Note written 2026-09-06; the live figures above take precedence over any numbers in it.

A 2025 action title with an epidemiological theme, released by a Russian indie studio with modest Steam traction.

Ebola Village sits in a difficult position: it carries niche appeal (80% positive sentiment among engaged players) but faces headwinds from low concurrent population, minimal developer engagement post-launch, and a premise that restricts mainstream discoverability. The residual margin is thin and shrinking; this is a watch candidate rather than an acquisition target unless the buyer has a specific use case for Russian-language catalog depth or experimental IP. The studio's fading status and two-title output suggest limited institutional capacity. Most realistic play: watch.

  • Risk: Thematic content (epidemiological framing) may limit algorithmic visibility and platform promotion, constraining organic growth.
  • Risk: Sample reviews cite janky UX and unclear first-task onboarding; technical polish gaps may explain churn after tutorial.
  • Risk: Developer has posted no updates in ~15 months and shows no signs of live-ops support or content roadmap.

This case as Markdown · Estimates carry ±30-50% error per title.